Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Tentamen (uitwerkingen)

CHAPTER 37: HEMATOLOGIC AND ONCOLOGIC EMERGENCIES {Urden: Critical Care Nursing, 9th Edition}

Beoordeling
-
Verkocht
-
Pagina's
19
Cijfer
A+
Geüpload op
18-04-2026
Geschreven in
2025/2026

MULTIPLE CHOICE 1. The nurse is caring for a patient with type 2 heparin-induced thrombocytopenia (HIT). The nurse knows that pulmonary embolism is a serious complication of HIT. Which findings would alert the nurse to the presence of this complication? a. Blanching of fingers and toes and loss of peripheral pulses b. Chest pain, pallor, and confusion c. Headache, impaired speech, and loss of motor function d. Dyspnea, pleuritic pain, and rales ANS: D The presence of blanching and the loss of peripheral pulses, sensation, or motor function in a limb indicate peripheral vascular thrombi. Neurologic signs and symptoms such as confusion, headache, and impaired speech can signal the onset of cerebral artery occlusion and stroke. Acute myocardial infarction may be heralded by dyspnea, chest pain, pallor, and alterations in blood pressure. Thrombi in the pulmonary vasculature may be evidenced by pleuritic pain, rales, and dyspnea. DIF: Cognitive Level: Applying REF: p. 911 | p. 912 | Table 37-5 OBJ: Nursing Process Step: Diagnosis TOP: Hematologic Disorders and Oncologic Emergencies MSC: NCLEX: Physiologic Integrity 2. The nurse is caring for a critically ill patient who is receiving heparin and understands that the patient is at risk for developing heparin-induced thrombocytopenia (HIT). Which intervention would be included into the patient’s plan of care to monitor for this potential complication? a. Monitor D-dimer levels every 5 to 10 hours from day 2 to day 5. b. Monitor prothrombin time (PT) every 5 to 14 hours from day 2 to day 12. c. Monitor platelet count every 2 or 3 days from day 4 to day 14. d. Monitor international normalized ratio (INR) every 5 days from day 10 to day 30. ANS: C Current guidelines suggest that for high-risk patients, platelet count monitoring should be performed every 2 or 3 days from day 4 to day 14. When a decrease in the platelet count is detected, heparin therapy should be discontinued immediately, and the patient should be tested for the presence of heparin antibodies. DIF: Cognitive Level: Applying REF: p. 912 OBJ: Nursing Process Step: Intervention TOP: Hematologic Disorders and Oncologic Emergencies MSC: NCLEX: Physiologic Integrity 3. The nurse is caring for a critically ill patient who is receiving heparin and understands that the patient is at risk for developing heparin-induced thrombocytopenia (HIT). Which previous medical conditions places this patient at risk for developing HIT? a. Sepsis b. Deep vein thrombosis c. Cardiac arrest d. Pneumonia

Meer zien Lees minder
Instelling
Vak

Voorbeeld van de inhoud

C HAPTER 37: H EMATOLOGIC AND
O NCOLOGIC E MERGENCIES
Urden: Critical Care Nursing, 9th Edition



MULTIPLE CHOICE


1. The nurse is caring for a patient with t ype 2 heparin -induced
thrombocytopenia (HIT). The nurse knows that pulmonary embolism is a
serious complicat ion of HIT. Which findings would alert the nurse to the
presence of this complication?
a. Blanching of fingers and toes and loss of peripheral pulses
b. Chest pain, pallor, and confusion
c. Headache, impaired speech, and loss of motor function
d. Dyspnea, pleuritic pain, and rales



ANS: D



The presence of blanching and the loss of peripheral pulses, sensation,
or motor function in a limb indicate peripheral vascular thrombi.
Neurologic signs and symptoms such as confusion, headache, and
impaired speech can signal the o nset of cerebral artery occlusion and
stroke. Acute m yocardial infarction may be heralded by dyspnea, chest
pain, pallor, and alterations in blood pressure. Thrombi in the
pulmonary vasculature may be evidenced by pleuritic pain, rales, and
dyspnea.

, DIF: Cognitive Level: Appl ying REF: p. 911 | p. 912 | Table
37-5 OBJ: Nursing Process Step: Diagnosis TOP:
Hematologic Disorders and Oncologic Emergencies MSC:
NCLEX: Physiologic Integrit y



2. The nurse is caring for a criticall y ill patient who is receiving heparin and
understands that the patient is at risk for developing heparin -induced
thrombocytopenia (HIT). Which intervention would be included into the
patient’s plan of care to monitor for this potential complication?
a. Monitor D-dimer levels every 5 to 10 hours from day 2 to day 5.
b. Monitor prothrombin time (PT) every 5 to 14 hours from day 2 to
day 12.
c. Monitor platelet count every 2 or 3 days from day 4 to day 14.
d. Monitor international normalized ratio (INR) every 5 days from day
10 to day 30.



ANS: C



Current guidelines suggest that for high -risk patients, platelet count
monitoring should be performed every 2 or 3 days from day 4 to day
14. When a decrease in the platelet count is detected, heparin therapy
should be discontinued immediatel y, and the patien t should be tested
for the presence of heparin antibodies.



DIF: Cognitive Level: Appl ying REF: p. 912 OBJ:
Nursing Process Step: Intervention TOP: Hematologic
Disorders and Oncologic Emergencies MSC: NC LEX:
Physiologic Integrit y

, 3. The nurse is caring for a criticall y ill patient who is receiving heparin and
understands that the patient is at risk for developing heparin -induced
thrombocytopenia (HIT). Which previous medical conditions places this
patient at risk for developing HIT?
a. Sepsis
b. Deep vein thrombosis
c. Cardiac arrest
d. Pneumonia



ANS: B



Ascertaining a medical history that includes previous heparin therapy,
deep vein thrombosis, or cardiovascular surgery that included the use
of cardiopulmonary bypass can alert the nurse to potential problems.



DIF: Cognitive Level: Appl ying REF: p. 912 OBJ:
Nursing Process Step: Assessment TOP: Hematologic
Disorders and Oncologic Emergencies MSC: NC LEX:
Physiologic Integrit y



4. What is the primary mechanism in the development of tumor lysis
s yndrome?
a. Destruction of platelets by l ymphocytic antibodies
b. Destruction of malignant cells through radiation or chemotherapy
c. Formation of heparin antibodies
d. Damage to the endothelium



ANS: B

Geschreven voor

Vak

Documentinformatie

Geüpload op
18 april 2026
Aantal pagina's
19
Geschreven in
2025/2026
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden

Onderwerpen

$4.18
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF


Ook beschikbaar in voordeelbundel

Maak kennis met de verkoper

Seller avatar
De reputatie van een verkoper is gebaseerd op het aantal documenten dat iemand tegen betaling verkocht heeft en de beoordelingen die voor die items ontvangen zijn. Er zijn drie niveau’s te onderscheiden: brons, zilver en goud. Hoe beter de reputatie, hoe meer de kwaliteit van zijn of haar werk te vertrouwen is.
RevisionTestBanks University of South Africa (Unisa)
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
133
Lid sinds
2 jaar
Aantal volgers
15
Documenten
663
Laatst verkocht
1 maand geleden

4.4

106 beoordelingen

5
73
4
13
3
17
2
0
1
3

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen